Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001
Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 748-752 Year: 2001
Polymorphic variation in surfactant protein B is associated with COPD exacerbations Source: Eur Respir J 2008; 32: 938-944 Year: 2008
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Association between the human surfactant protein-A (SP-A) gene locus and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006
Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis Source: Eur Respir J 2011; 37: 18-25 Year: 2011
Increased expression of phosphodiesterase 4 (PDE4) A, B and D in alveolar macrophages from chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease Year: 2011
Detoxifying enzymes genes (EPHX1, CYP1A1 and GSTP1) genotypes and risk of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 196s Year: 2003
Elastin expression in very severe human COPD Source: Eur Respir J 2009; 33: 324-331 Year: 2009
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Definition of trypsin-like enzymes activity as the marker of severity of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018
The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006
Polymorphism of collagen I gene and glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease associated with cardiovascular disease Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011